Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Vranckx

Showing results (161-170 of 305) with videos related to

Pageof 31
Sort By:
Lancet (London, England)|September 7, 2012
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trialEdoardo Camenzind, William Wijns, Laura Mauri, et al.
Circulation|May 2, 2007
Clinical end points in coronary stent trials: a case for standardized definitionsDonald E Cutlip, Stephan Windecker, Roxana Mehran, et al.
Open Heart|January 28, 2025
Parsimonious versus extensive bleeding score: can we simplify risk stratification after percutaneous coronary intervention and reduce bleeding events by de-escalation of the antiplatelet strategy?Eva Christine Ida Woelders, Yoshinobu Onuma, Kai Ninomiya, et al.
Journal of the American Heart Association|September 17, 2021
Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre-Specified Analysis of the GLOBAL LEADERS TrialPascal Vranckx, Marco Valgimigli, Ayodele Odutayo, et al.
Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.
Journal of the American College of Cardiology|March 10, 2018
The Radial Artery for Percutaneous Coronary Procedures or Surgery?Mario Gaudino, Francesco Burzotta, Faisal Bakaeen, et al.
Heart (British Cardiac Society)|March 8, 2013
Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE ProgramVasim Farooq, Pascal Vranckx, Laura Mauri, et al.
Circulation|November 8, 2021
Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical TrialRoberto Galea, Federico De Marco, Nicolas Meneveau, et al.
Journal of the American College of Cardiology|May 13, 2022
Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the WeekChristophe Vandenbriele, Deepa J Arachchillage, Pascal Frederiks, et al.
American Heart Journal|November 29, 2016
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO studyStephan Windecker, Jan Tijssen, Gennaro Giustino, et al.
Pageof 31

Showing results (161-170 of 305) with videos related to

Sort By:
Pageof 31
Lancet (London, England)|September 7, 2012
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trialEdoardo Camenzind, William Wijns, Laura Mauri, et al.
Circulation|May 2, 2007
Clinical end points in coronary stent trials: a case for standardized definitionsDonald E Cutlip, Stephan Windecker, Roxana Mehran, et al.
Open Heart|January 28, 2025
Parsimonious versus extensive bleeding score: can we simplify risk stratification after percutaneous coronary intervention and reduce bleeding events by de-escalation of the antiplatelet strategy?Eva Christine Ida Woelders, Yoshinobu Onuma, Kai Ninomiya, et al.
Journal of the American Heart Association|September 17, 2021
Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre-Specified Analysis of the GLOBAL LEADERS TrialPascal Vranckx, Marco Valgimigli, Ayodele Odutayo, et al.
Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.
Journal of the American College of Cardiology|March 10, 2018
The Radial Artery for Percutaneous Coronary Procedures or Surgery?Mario Gaudino, Francesco Burzotta, Faisal Bakaeen, et al.
Heart (British Cardiac Society)|March 8, 2013
Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE ProgramVasim Farooq, Pascal Vranckx, Laura Mauri, et al.
Circulation|November 8, 2021
Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical TrialRoberto Galea, Federico De Marco, Nicolas Meneveau, et al.
Journal of the American College of Cardiology|May 13, 2022
Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the WeekChristophe Vandenbriele, Deepa J Arachchillage, Pascal Frederiks, et al.
American Heart Journal|November 29, 2016
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO studyStephan Windecker, Jan Tijssen, Gennaro Giustino, et al.
Pageof 31